Knowledge networking to support medical new product development

Decision Support Systems

Volumn 43, Issue 4, 2007, Pages 1255-1273

  Mohan, Kannan ^a   Jain, Radhika ^b   Ramesh, Balasubramaniam ^c  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b UNIVERSITY OF MEMPHIS   (United States)

^c GEORGIA STATE UNIVERSITY   (United States)

Author keywords

Healthcare; Knowledge integration; Knowledge networks; New product development; Pharmaceutical knowledge management

Indexed keywords

DISTRIBUTED DATABASE SYSTEMS; DRUG PRODUCTS PLANTS; HOSPITAL DATA PROCESSING; KNOWLEDGE ENGINEERING; SOFTWARE PROTOTYPING;

KNOWLEDGE INTEGRATION; KNOWLEDGE NETWORKS; PHARMACEUTICAL KNOWLEDGE MANAGEMENT;

DECISION SUPPORT SYSTEMS;

EID: 34547678141     PISSN: 01679236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dss.2006.02.005     Document Type: Article

References (36)

1. Abbott R. An overview of knowledge integration for innovation in healthcare and pharmaceuticals. Drug Information Journal 32 (1998) 905-915
2. Alavi M., and Tiwana A. Knowledge integration in virtual teams: the potential role of KMS. Journal of the American Society for Information Science and Technology 53 (2002) 1029-1037
3. Bloom T., and Bunn G. Clinical information platforms: infrastructure for clinical development. Drug Information Journal 35 (2001) 781-789
4. Carlile P., and Rebentisch E. Into the black box: the knowledge transformation cycle. Management Science 49 (2003) 1180-1195
5. Conklin E.J., and Begeman M. GIBIS: a hypertext tool for exploratory policy discussion. Presented at the ACM Conference on Computer-Supported Cooperative Work, Portland, Oregon, United States (1988)
6. Crow K. Design for Manufacturability (2001)
7. De Boer M., V. d. Bosch, and F. A.J. Managing organizational knowledge integration in the emerging multimedia complex. Journal of Management Studies 36 (1999) 120-123
8. Facts and statistics from the pharmaceutical industry. The Association of the British Pharmaceutical Industry (2004)
9. Glen J.M.W., and Lord M. New product development processes within the UK medical device industry. Medical Engineering and Physics 18 (1996) 670-676
10. Good Clinical Practice in FDA-regulated clinical trials (2004). http://www.fda.gov/oc/gcp/default.htm
11. Good Laboratory Practices (2004). http://www.fda.gov/ora/compliance_ref/bimo/glp/default.htm
12. Grant R. Prospering in dynamically-competitive environments: organizational capability as knowledge integration. Organization Science 7 (1996) 375-387
13. Hansen M. Knowledge networks: explaining effective knowledge sharing in multiunit companies. Organization Science 13 (2002) 232-248
14. Hodgman C. An information-flow model of the pharmaceutical industry. Drug Discovery Today 6 (2001) 1256-1258
15. Hughes D. Dizzying but scary: looking towards R&D in 2005. Drug Discovery Today 4 (1999) 393-395
16. Innovation or Stagnation: Challenges and opportunities on the critical path to new medical product," U.S. Department of Food and Health Services, Food and Drug Administration (FDA), 2004.
17. Jansen-Vullers M.H., van Dorp C.A., and Beulens A.J.M. Managing traceability information in manufacture. International Journal of Information Management 23 (2003) 395-413
18. Koretz S., and Lee G. Knowledge management and drug development. Journal of Knowledge Management 2 (1998) 53-58
19. Kubler J., and Weihrauch T. Integrated summaries and meta-analyses in clinical drug development. Drug Information Journal 36 (2002) 127-133
20. Liebowitz J. Knowledge management receptivity at a major pharmaceutical company. Journal of Knowledge Management 4 (2000) 252-258
21. Liongosari E. Accelerating Drug Discovery Process through Model-Based Knowledge Integration. Presented at KMWorld and Intranets, Santa Clara, CA (2002)
22. Neumann E., and Thomas J. Knowledge assembly for the life sciences. Drug Discovery Today 7 (2002) s160-s162
23. Pharmaceutical cGMPs for the 21st century - a risk-based approach, Department of Health and Human Services, U.S. Food and Drug Administration, 2004.
24. Ramesh B., and Dhar V. Representing and maintaining process knowledge for large-scale systems development. IEEE Expert 9 (1994) 54-59
25. Ramesh B., and Jarke M. Towards reference models for requirements traceability. IEEE Transactions on Software Engineering 27 (2001) 58-93
26. "Roche-Corporate Media News," 2002.
27. Rochford L., and Rudelius W. New product development process: stages and successes in the medical products industry. Industrial Marketing Management 26 (1997) 67-84
28. Roth J. Enabling knowledge creation: learning from an R&D organisation. Journal of Knowledge Management 7 (2003) 32-48 10.1108/13673270310463608
29. Sapienza A., and Lombardino J. Recognizing, appreciating, and capturing the tacit knowledge of R&D scientists. Drug Development Research 57 (2002) 51-57
30. Spiguel C. The pharmaceutical industry in the 21st century: surviving in the e-business environment. Drug Information Journal 34 (2000) 709-723
31. Stasser G., Vaughan S., and Stewart D. Pooling unshared information: the benefits of knowing how access to information is distributed among group members. Organizational Behavior and Human Decision Processes 82 (2000) 102-116
32. Styhre A., Ingelgård A., and Roth J. A nonreductionist view of knowledge: product development in the pharmaceutical industry. Emergence 2 (2000) 51-67
33. Tiwana A., and Ramesh B. Integrating knowledge on the web. IEEE Internet Computing (2001 May/June) 32-39
34. Voorde K.V.d., and Reygaert K. System audit of a megatrial. Drug Information Journal 35 (2001) 469-473
35. Whitmore E. Product Development Planning for Health Care Products Regulated by the FDA (1997), ASQC Quality Press, Milwaukee, Wisconsin
36. Yin R.K. Case Study Research: Design and Methods (1989), Sage Publications, Beverly Hills, CA